BackEhouse Global Overview

Ehouse Global EBIT

Track Ehouse Global's EBIT ($-1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.50M
↓ 202.19% YoY

As of Mar 31, 2015

Annual EBIT (TTM)

-$1.81M
↓ 138.69% YoY

Trailing 12 months ending Mar 31, 2015

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ehouse Global (EHOS) FAQ

The latest EBIT for EHOS is $-1.8M as of March 2015. That compares with $-760K in the prior-year period — down 138.7% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside Ehouse Global's historical trend and sector peers before judging valuation or financial health.

Over the past year, EHOS's EBIT moved from $-760K to $-1.8M — a 138.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ehouse Global's operating scale or balance-sheet position.

Against Healthcare companies, EHOS currently prints $-1.8M for EBIT, while the sector average sits near $130B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Ehouse Global's growth, margins, and balance sheet.

A EBIT figure of $-1.8M for EHOS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting EHOS's EBIT ($-1.8M), review year-over-year change from $-760K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.